Q2 2026 Holdings
Filed 2026-08-12 | 15 holdings | $1.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Veradermics, Inc.(MANE) | Common Stock | 922967104 | $295.3M | 2,401,868 | 28.4% |
| Zenas BioPharma, Inc(ZBIO) | Common Stock | 98937L105 | $127.9M | 5,037,854 | 12.3% |
| Crispr Therapeutics AG(CRSP) | Common Shares | H17182108 | $111.2M | 2,038,763 | 10.7% |
| Avalyn Pharma, Inc(AVLN) | Common Stock | 05348Y105 | $108.9M | 3,308,649 | 10.5% |
| Design Therapeutics, Inc.(DSGN) | Common Stock | 25056L103 | $94.4M | 6,526,476 | 9.1% |
| Odyssey Therapeutics, Inc.(ODTX) | Common Stock | 67613T104 | $71.0M | 3,794,883 | 6.8% |
| Alumis Inc.(ALMS) | Common Stock | 022307102 | $55.2M | 1,959,896 | 5.3% |
| Oric Pharmaceuticals, Inc.(ORIC) | Common Stock | 68622P109 | $50.0M | 4,615,384 | 4.8% |
| Mineralys Therapeutics Inc.(MLYS) | Common Stock | 603170101 | $42.2M | 1,563,966 | 4.1% |
| ARS Pharmaceuticals, Inc.(SPRY) | Common Stock | 82835W108 | $32.1M | 4,012,903 | 3.1% |
| Mobia Medical, Inc(MOBI) | Common Stock | 60705V103 | $26.6M | 1,986,072 | 2.6% |
| Nkarta, Inc.(NKTX) | Common Stock | 65487U108 | $9.4M | 3,333,333 | 0.9% |
| Oculis Holding AG(OCS) | Ordinary Shares | H5870P102 | $8.9M | 641,022 | 0.9% |
| Ultragenyx Pharmaceutical Inc.(RARE) | Common Stock | 90400D108 | $4.6M | 137,753 | 0.4% |
| enGene Holdings Inc.(ENGN) | Common Shares | 29286M105 | $1.3M | 747,750 | 0.1% |